Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TAVI for Pure Native Aortic Regurgitation: Are We There Yet?
Author(s): Eduardo A Arias , Amit Bhan , Zhan Lim , et al Added: 3 years ago
During the past decade, transcatheter aortic valve implantation (TAVI) has revolutionised the interventional treatment of aortic stenosis (AS).1 It has rapidly evolved from a treatment used on a compassionate basis for inoperable patients to being the standard of care in high-risk AS.2,3 In that cohort it has proven to be non-inferior to surgical aortic valve replacement (SAVR) in terms of… View more

Vascular Disease and Surgery

Intervention
EuroPCR 22: JenaValve TAVR System for the Treatment of Aortic Regurgitation
Author(s): Stephan Baldus Added: 1 year ago
Filmed at EuroPCR 2022, Prof Stephan Baldus (University of Köln Medical Center, DE) outlines the first results from a study investigating the use of the JenaValve TAVR device in treating patients with aortic regurgitation. Discussion Points: 1. Prevalence and burden of aortic regurgitation 2. Treatment options 3. Importance of the technology 4. Considerations and further research Recorded at… View more

Intervention
TAVI for Pure Aortic Regurgitation With Dedicated Devices
Author(s): Pierluigi Costanzo , Paul Bamborough , Mark Peterson , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation
Author(s): Roberto Spina , Chris Anthony , David WM Muller , et al Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high… View more

Vascular Disease and Surgery

Intervention
Author(s): Crochan J O’Sullivan , Peter Wenaweser Added: 3 years ago
Since the first ‘proof-of-concept’ case of transcatheter aortic valve implantation (TAVI) was reported by Cribier and colleagues in 2002, more than 200,000 patients have undergone the procedure in approximately 65 countries.1,2 Since its inception, the majority of patients undergoing TAVI have been considered inoperable or high risk for conventional surgical aortic valve replacement (SAVR) as… View more

Vascular Disease and Surgery

Standards & Guidelines
First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic Protection System During Transcatheter Aortic Valve-in-valve Implantation
Author(s): Dariusz Jagielak , Radoslaw Targonski , Dariusz Ciecwierz Added: 3 years ago

Vascular Disease and Surgery

Prevention & Chronic Conditions
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention
Author(s): John Jose , Gert Richardt , Mohamed Abdel-Wahab Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter… View more

Vascular Disease and Surgery

Intervention
Author(s): Simon Kennon , Zhan Lim Added: 3 years ago
The main advantages of transcatheter aortic valve implantation (TAVI) over conventional aortic valve replacement (cAVR) surgery are the avoidance of sternotomy, heart lung bypass and prolonged procedure times. These advantages facilitate early mobilisation and discharge – important both clinically and in terms of resource utilisation. Balanced against this, TAVI is less predictable than cAVR –… View more

Vascular Disease and Surgery

Standards & Guidelines